12/1/22
Important Update for NIH SBIR/STTR Jan 5 & April 5 SBIR/STTR Applicants!
The U.S. Small Business Administration (SBA) has increased the National Institutes of Health (NIH) statutory budget guidelines for all SBIR/STTR applications coming through the Omnibus FOAs to the following amounts:
- Phase I Awards: $295,924 total costs(direct costs, indirect costs, fee)
- Phase II Awards $1,972,828 total costs(direct costs, indirect costs, fee)
Applicants proposing projects falling under an SBA-approved waiver topic MAY be allowed to exceed these total award amounts. For more information and a list of current topics, click on the following link:
See the following links for NIH Solicitations:
HHS Omnibus (NIH)
Clinical Trails not allowed:
PA-22-176 SBIR-NIH, CDC & FDA
PA-22-178 STTR-NIH
Clinical Trials Required:
PA-22-177 SBIR-NIH
PA-22-179 STTR-NIH
PHS 2022-2 Program Descriptions & Research Topics Document
2022 SBA approved topics list for budget waivers
